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ABSTRACT
Cutaneous leishmaniasis (CL) is an endemic disease in the Republic of Panama, caused by 
Leishmania (Viannia) parasites, whose most common clinical manifestation is the presence of 
ulcerated lesions on the skin. These lesions usually present a chronic inflammatory reaction, 
sometimes granulomatous, with the presence of lymphocytes, plasma cells and macrophages. 
This study describes the histopathological characteristics found in the skin lesions of patients 
with CL caused by Leishmania (V.) panamensis in Panama. We analyzed 49 skin biopsy 
samples from patients with clinical suspicion of CL, by molecular tests (PCR for subgenus 
Viannia and HSP-70) and by Hematoxylin-Eosin staining. Samples were characterized at the 
species level by PCR-HSP-70/RFLP. From the 49 samples studied, 46 (94%) were positive 
by PCR and were characterized as Leishmania (V.) panamensis. Of these, 48% were positive 
by Hematoxylin-Eosin staining with alterations being observed both, in the epidermis (85%) 
and in the dermis (100%) of skin biopsies. The inflammatory infiltrate was characterized 
according to histopathological patterns: lymphohistiocytic (50%), lymphoplasmacytic (61%) 
and granulomatous (46%) infiltration, being the combination of these patterns frequently 
found. The predominant histopathological characteristics observed in CL lesions caused by 
L. (V.) panamensis in Panama were: an intense inflammatory reaction in the dermis with 
a combination of lymphohistiocytic, lymphoplasmacytic and granulomatous presentation 
patterns and the presence of ulcers, acanthosis, exocytosis and spongiosis in the epidermis.
KEYWORDS: Cutaneous leishmaniasis. Leishmania Viannia panamensis. Histopathology. 
Panama. 
INTRODUCTION
Cutaneous leishmaniasis (CL) is a zoonotic disease caused by parasites of the 
genus Leishmania, which infects mammalian reservoirs through the bite of an 
infected vector of the genus Lutzomyia in the New World and Phlebotomus in the 
Old World1,2. Leishmaniasis is among the group of neglected tropical infections, 
leading to high levels of morbidity mainly among the most vulnerable social 
groups3,4. In Panama, it is considered an emerging health problem with an estimated 
1,000-3,000 new cases per year5. In 2011, the Pan American Health Organization 
(PAHO) reported Panama as the country with the highest incidence of CL per 
100,000 habitants in the American continent6. 
CL presents a spectrum of clinical and histopathological manifestations that 
encompass different morphological states such as a nodule, plaque and ulcer; and 
which may persist as a chronic lesion or heal with a scar, depending on the infecting 
parasite species7. The lesion may later recur8. Commonly, the infection presents 
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as cutaneous lesions in exposed areas of the patient, being 
the skin the main affected organ. Once the parasite invades 
the skin, after the innate immune response, the defense 
against infection is the cell-mediated immune response, 
which actively participates in the formation of granuloma 
eventually limiting the spread of the infectious agent and, 
in this way, controlling the infection1. 
Because the current CL treatment is complicated and 
is often associated with drugs that have adverse effects, 
diagnostic confirmation prior to treatment is important. 
The main diagnostic data are clinical and epidemiological; 
however, additional laboratory testing is required for 
definitive diagnosis. Several diagnostic tests are available 
to confirm the diagnosis: parasitological, immunological, 
histopathological, immunopathological and molecular9. 
Histopathological techniques are important because 
they allow observing the parasite and studying the 
inflammatory infiltrate that is produced during infection 
by Leishmania parasites9-11. The cutaneous lesion of 
leishmaniasis is characterized by a chronic inflammatory 
reaction, sometimes granulomatous, with the presence of 
lymphocytes, plasma cells and macrophages. Leishmania 
amastigotes are found in the cytoplasm of macrophages as 
rounded organisms, with a round nucleus, a kinetoplast and 
surrounded by a clear halo9,11,12. Two histological patterns 
have been reported in patients with active CL lesions. The 
first one is a non-specific chronic inflammatory reaction 
with a diffuse infiltrate of lymphocytes, plasma cells, 
macrophages, granulocytes and cell debris. The second one, 
a granulomatous reaction that contains histopathological 
elements found in a chronic inflammatory reaction, but 
associated with the presence of epithelioid cells and the 
formation of granulomas, frequently associated with 
giant cells. Vasculitis, neuritis and necrosis have also 
been observed. In scarred lesions, dermal fibrosis and 
perivascular infiltrates can be found13. The first reports of 
CL in Panama were those described by Darling in 191114, 
Herrick in 191115, Darling and Connor in 191116 and Bates 
in 191317, who considered the lesions clinically identical to 
the oriental sore. Fox in 193118 summarized the clinical and 
gross features of the disease as seen in Brazil, but did not 
stress the histological aspects, which were later summarized 
by Snow et al. in 194819. However, there is only one detailed 
report from 1952 describing the histopathological changes 
in skin lesions of patients affected by CL in Panamá20. The 
results showed a rather constant and distinctive histological 
pattern presented in 20 skin ulcer biopsies due to CL. The 
cardinal findings of epithelial hyperplasia, poor granulation, 
intense chronic inflammation of the dermal papillae, 
inflammatory cells located on sweat glands towards the 
periphery of the lesion, and lack of blood vessel changes, 
differentiate leishmaniasis from most cutaneous ulcers; 
however, positive diagnosis still requires the demonstration 
of the presence of parasites20. 
Considering that the histopathological characteristics 
of these lesions, as well as their diagnostic and predictive 
value have been poorly documented in Panama, this study 
had the main aim to describe the histopathological findings 
of cutaneous lesions caused by Leishmania (V.) panamensis 
in patients from Panama. 
MATERIALS AND METHODS
Study design
This study aimed to describe the histopathological 
features of skin biopsies from patients with CL in Panama. 
Patients with suspected CL were attended at the Tropical 
Medicine Clinic, Gorgas Memorial Institute of Health 
Studies, Panama City. This study was carried out from 
January 2012 to December 2012. All patients were adults, 
and accepted, freely and voluntarily, to participate in the 
study through the signing of informed consents. Patients 
were biopsied and the histopathological and molecular 
diagnosis of CL was performed. After CL diagnosis, 
all patients were treated with meglumine antimonate 
(Glucantime™) in a dose of 20 mg/kg/body weight, 
intramuscularly for 20 days, according to the Panamanian 
guidelines for Leishmaniasis control21. 
Biopsy collection 
Forty-nine skin biopsy samples from patients with 
suspected CL attended at the Tropical Medicine Clinic, 
Gorgas Memorial Institute of Health Studies, were 
evaluated. Biopsy specimens were taken with a 5-mm 
Harris punch (Whatman International Ltd), preceded by 
the application of local anesthesia and asepsis1,22. 
Molecular characterization
DNA extraction from the biopsy samples was performed 
using the Qiagen QIamp® DNA Blood Mini Kit (Qiagen, 
CA, USA) according to the manufacturer’s instructions. 
Two protocols based on the polymerase chain reaction 
(PCR) were used: a PCR to identify the subgenus Viannia 
(LV-B1 primers), which amplifies the kDNA region of the 
minicircle yielding a 750 pb23 fragment; and the Hsp-70 
PCR (F25-R1310 primers) that amplifies a region from 
the Heat Shock Protein 70 gene yielding a product of 
1,286 pb24. In addition, samples were characterized by 
PCRHsp-70/RFLP analysis using the enzymes HaeIII and 
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BccI to observe the distinct patterns of Leishmania species 
that have been previously described25,26. 
Histopathological analysis
All samples were fixed in 10% buffered formalin, 
and processed within a period of not more than 48 h to 
dispose of the paraffin tissue block27,28, in the Laboratory 
of Pathology of Santo Tomas Hospital, Panama city. 
All tissue samples were dehydrated, cleared, embedded 
in paraffin, cut into 4–5 μm thick sections and stained 
with Hematoxylin-Eosin (HE) and Giemsa22. Lesion 
sections were characterized microscopically based on the 
histological alterations found in the epidermis and in the 
dermis. At the same time, the intensity and distribution of 
inflammatory reactions in the dermis were evaluated, as 
well as the presence of different cell types present in the 
infiltrate, the formation of granuloma and the parasite load, 
among other morphological aspects. A comparative, semi-
quantitative histopathological analysis of the HE-stained 
sections was performed, attributing crosses according to 
the intensity of the different characterized processes: (-) 
negative, (+) discrete, (++) moderate and (+++) intense29. 
RESULTS
Cutaneous lesions of 49 CL-suspected patients were 
analyzed using molecular and histopathological methods. 
Of the patients studied, 73% were male and 27% female. 
Most of the patients (96%) came from the province of 
Panama. The age range was 23 to 71 years with an average 
of 41 years old. Evolution time of lesions varied from 10 to 
90 days with an average of 30 days. The number of lesions 
ranged from 1 to 8 with an average of 2 lesions per patient, 
mostly located in the upper limbs (60%). Out of the total 
samples, 94% (46/49) were positive by PCR (Viannia, 
Hsp-70). Positive PCR Hsp-70 samples (78%, 36/46) were 
characterized as L. (V.) panamensis by PCR-RFLP analysis. 
Forty-eight percent (22/46) of the samples were positive 
to amastigotes by microscopic evaluation of histological 
sections. In patients with CL lesions of 30 days or less (early 
lesions), 11 were positive and 13 were negative; and in 
patients with lesions of more than 30 days of infection (late 
lesions), 11 were positive and 11 were negative. Moreover, 
the amount of parasites varied between discreet (+) and 
intense (+++) in the two groups. Amastigote forms were 
observed in typical histiocyte phagocytic vacuoles, visible 
in HE staining (Figure 1). The parasite load presented a 
variable distribution in both, superficial and middle dermis 
and even deeper in the subcutaneous fat, with occasional 
signs of endarteritis. 
The histopathological analysis from the 46 skin biopsies 
of patients with clinical and laboratory diagnosis of localized 
CL caused by L. (V.) panamensis showed morphological 
alterations in both, epidermis and dermis. Alterations of the 
epidermis were observed in 85% (39/46) of skin biopsies; 
and were mainly characterized by acanthosis in 41% (19/46), 
spongiosis in 39% (18/46), exocytosis in 35% (16/46), 
parakeratosis in 17% (8/46) and pseudoepitheliomatous 
hyperplasia in 7% (3/46) of the cases (Figure 2). The 
presence of ulcers in the fundus, border and surface of 
epidermis was observed in 43% (20/46) of skin biopsies 
(Table 1). However, the histopathological alterations in the 
superficial and deep dermis occurred in 100% of the cases 
and were characterized mainly by a lymphoplasmocytic 
inflammatory infiltrate of variable intensity, with diffuse 
or focal distribution. The inflammatory infiltrate was 
intense in 39% (18/46), moderate in 57% (26/46) and 
mild in 4% (2/46) of the cases with diffuse distribution 
in 37% (17/46) and focal in 63% (29/46) of the cases. 
Milder infiltrates were preferentially located in superficial 
dermis with tendency of perivascular distribution. The 
inflammatory infiltrate was characterized by predominance 
of lymphocytes (61%), followed by histiocytes (22%) and 
plasma cells (20%). Granulomatous outline or well-formed 
epithelioid granulomas were observed in 46% (21/46) of 
the cases, with the presence of multinucleated giant cells 
in 24% (5/21) and focal necrosis area in 14% (3/21) of 
these cases. The presence of Leishmania amastigote forms 
in macrophage cytoplasm was observed in 48% (22/46) 
of HE-stained histological sections and the parasite load 
varied from mild, moderate to intense (Table 2). According 
to different inflammatory cells predominance in the dermal 
tissue response, it was possible to classify them into three 
Figure 1 - Amastigotes forms of Leishmania inside macrophages 
vacuoles in the dermis of patients affected by localized 
cutaneous leishmaniasis caused by L. (V.) panamensis (red 
arrows). (Hematoxilin-Eosin staining)
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histopathological patterns: lymphohistiocytic infiltration 
in 50% (23/46), lymphoplasmocytic in 61% (28/46) and 
granulomatous in 46% (21/46), being the combination of 
these patterns frequently found (Figure 3).
DISCUSSION
At least 95% of leishmaniasis cases reported in Panama 
correspond to cutaneous lesions of chronic evolution30. The 
clinical diagnosis of these lesions is often complicated, even 
for physicians experienced in the recognition and treatment 
of this parasitic disease. On the other hand, it is common 
to send histological samples of patients with suspected CL 
lesions to pathology units of reference Panamanian health 
institutions in which pathologists must have previous 
experience and academic background. However, studies 
aimed to characterize CL histopathological findings in 
Panama are scarce and consequently necessary for the 
diagnostic and prognostic support of these parasitic 
infections that are so frequent in this country20.
In this work, evaluation by histopathology of 46 
patient’s lesions with CL previously characterized by 
Table 1 - Histopathological findings observed in the epidermis of patients with cutaneous leishmaniasis caused by Leishmania 
(V.) panamensis in Panama
EPIDERMIS
Ulcer Acanthosis Spongiosis Exocytosis Paraqueratosis Hyperplasia
Number 20/46 19/46 18/46 16/46 8/46 3/46
Percentage (%) 43 41 39 35 17 7
Figure 2 - Paraffin histological section of the skin lesion of a patient affected by localized cutaneous leishmaniasis caused by L. 
(V.) panamensis showing in A) acanthosis (black arrow), and in B) spongiosis (yellow arrow) and lymphohistiocytic exocytosis (blue 
arrow) (Hematoxilin-Eosin staining)
Table 2 - Histopathological findings observed in the dermis of patients with cutaneous leishmaniasis caused by Leishmania (V.) 
panamensis in Panama
DERMIS – INFLAMMATORY INFILTRATE
AmastigoteINTENSITY DISTRIBUTION CELLULAR TYPE
Intense Moderate Discrete Diffuse Focal *PMN Lymphocyte  Plasma cell  Macrophage
Number 18/46 26/46 2/46 17/46 29/46
38/46 (-) 
8/46 (+) 
0/46 (++) 
0/46 (+++)
0/46 (-) 
2/46 (+) 
15/46 (++) 
29/46 (+++)
2/46 (-) 
14/46 (+) 
20/46 (++) 
10/46 (+++)
1/46 (-) 
19/46 (+) 
15/46 (++) 
11/46 (+++)
24/46 (-) 
15/46 (+) 
2/46 (++) 
5/46 (+++)
Percentage 
(%) 39 57 4 37 63
83 (-) 
17 (+) 
0 (++) 
0 (+++)
0 (-) 
4 (+) 
33 (++) 
63 (+++)
4 (-) 
30 (+) 
44 (++) 
22 (+++)
2 (-) 
41 (+) 
33 (++) 
24 (+++)
52 (-) 
33 (+) 
4 (++) 
11 (+++)
*PMN: Polimorphonuclear
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molecular tests was achieved. However, amastigotes were 
only detected in 48% (22/46) of biopsies. Amastigotes 
identified within histiocytes presented a variable distribution 
along the superficial, middle and deeper layers of dermis. 
This relatively low diagnostic sensitivity has also been 
reported in studies with other Leishmania species which 
are present in South America10,31-33. Nevertheless, in these 
previous reports, it was considered that histopathological 
tests were important to describe the inflammatory infiltrate 
associated to leishmaniasis34. According to the literature, 
histopathology is usually the method with the lowest 
diagnostic sensitivity (30% -60%) for CL9,32,35. There 
are several factors that can explain the difficulties of CL 
diagnosis by histopathological analysis. One of them 
occurs in the later stages of the cutaneous infection when 
granulomas predominate and parasite-filled histiocytes 
gradually disappear9,36. In this regard, it has been reported 
that parasites are very difficult to find in lesion biopsies 
with 5-7 months of evolution37,38. Thus, we evaluate 23 
patients with early lesions (up to 30 days) and 22 with late 
lesions (31-90 days). However, we did not find statistical 
differences between the two groups regarding amastigote 
detection and parasite load. Another situation occurs when 
there are several opportunistic infections in the same lesion 
or the same cell type in necrotic areas, making it difficult 
to observe amastigote forms. The same happens when 
parasites are free in connective tissues36. Occasionally, the 
histopathological analysis fails to detect amastigotes even in 
early lesions37 which are rarely reported in the epidermis8. 
Chronic nonspecific and/or granulomatous inflammation 
are the main histopathological manifestations of cutaneous 
and mucocutaneous leishmaniasis in the New World9,39. 
The associated infiltration of plasma cells and vascular 
alterations are suggestive but not diagnostic features of 
the disease20,37,39. The specific diagnosis is only possible 
through the demonstration of parasites in examined tissues29. 
As already mentioned, parasites are generally scarce and 
difficult to demonstrate in more chronic lesions, thus, 
immunostaining techniques could be employed to increase 
the sensitivity of the histopathological diagnosis37,38. 
However, there are studies, using immunostaining 
techniques, that demonstrated that it is possible to obtain 
Figure 3 - Inflammatory patterns observed in cutaneous lesions caused by Leishmania (V.) panamensis. A) Intense and diffuse 
lymphohistiocytic inflammatory pattern; B) Intense lymphoplasmocytic inflammatory pattern; C) Granulomatous inflammatory pattern; 
D) Presence of multinucleated giant cells observed in the granulomatous reaction (Hematoxilin-Eosin staining)
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higher sensitivities in CL histopathological diagnosis10,33,40. 
In this sense, Sotto et al.39 analyzed 40 biopsies of human 
patients with cutaneous or mucocutaneous leishmaniasis in 
South America, evidencing the presence of parasites in 20% 
of biopsies in histological sections stained by HE, while 
by indirect immunofluorescence of paraffin-embedded 
tissues, the positivity increased to 89.28% and by the 
immunoperoxidase reaction, it was possible to visualize 
the parasite in 64.51% of biopsies. 
Morphological analysis of lesions showed a variable 
parasite load (discrete to intense) and inflammatory 
infiltrates of variable intensity with diffuse or focal 
distribution. Inflammatory infiltrates were characterized 
by lymphocytes predominance, followed by histiocytes and 
plasma cells. The epidermis showed acanthosis, spongiosis, 
exocytosis, parakeratosis and pseudoepitheliomatous 
hyperplasia. In addition, lesions demonstrated the 
presence of ulcers, focal necrosis area and well-organized 
granulomas. The presence of well-organized granulomas 
with multinucleated giant cells is a factor related to the 
immune system attempt to eliminate parasites41. Similar 
histopathological features have been described in previous 
studies which analyzed biopsies obtained from patients 
infected with species from the Viannia subgenus33,34,41-43.
In the present study, 63% (29/46) of the tissue 
inflammatory response was found to be focal in the tissue, 
in contrast to data reported by Isaza et al.1, showing that 
inflammatory response was diffuse (62.5%) in biopsies 
of patients coming from endemic areas of the State of 
Antioquia in Colombia. These patients had CL caused by 
L. (V.) panamensis. In addition, Isaza et al.1 described a 
predominance of macrophages and lymphocytes in the 
inflammatory infiltrate in accordance with our study. At 
the epidermis level, we found the presence of exocytosis in 
35% of the samples. This cellular process was also observed 
(69.5%) in the study by Isaza et al.1 The presence of the 
exocytosis phenomenon emphasizes the importance of the 
epidermis in the immunoregulation of the disease44.
The histological spectrum of CL has had variations in 
its classification in different types. For example, Kurban 
et al.45 and Mansour et al.46, suggested two histological 
patterns in biopsies of patients with CL: the first one 
corresponding to lesions with less than one year of 
duration associated with a diffuse infiltrate, and the second 
one corresponding to lesions of more than one year of 
duration with granulomatous infiltrate. On the other hand, 
Venkataram et al.37 reported four histological patterns 
suggestive of CL. Moreover, Magalhães et al.22 and Ridley 
et al.47 described up to five histopathological patterns. In 
the present study, three main histopathological patterns 
were identified: the first one with a lymphohistiocytic 
inflammatory response found in 50% of samples, the second 
one with a lymphoplasmacytic response, present in 61% of 
samples and the third one with a granulomatous response, 
found in 46% of samples. It is important to mention that 
sometimes these patterns appear combined. For example, 
Azogue48 describes a histiolymphoplasmocytic response in 
66% of CL cases associated with granulomatous reactions 
and Magalhães et al.24 described that 40.9% of CL cases 
had characteristic histiolymphoplasmocytic responses 
with cellular exudative reaction patterns and disorganized 
granulomatous reactions in 26.1% of biopsies. In contrast, 
Isaza et al.1 did not find granulomatous infiltrates in his 
study.
The histopathological and immunological host 
response to infection caused by parasites of the genus 
Leishmania, depends largely on the infecting parasite 
species7,49. In this sense, Silveira et al.34 described 
the clinical and immunopathological spectrum of the 
American CL, caused by different dermotropic species of 
the parasite responsible for the disease in the New World. 
While L. (V.) braziliensis presents a clear tendency to lead 
to localized cutaneous leishmaniasis (moderate T-cell 
hypersensitivity response), progressing to mucocutaneous 
leishmaniasis (prominent Th1 type immune response), L. 
(Leishmania) amazonensis shows an opposite tendency, 
leading infection to the anergic T-cell hyposensitivity 
pole, in association with a Th2 type of cellular immune 
response. The cellular immune response of the host also 
influences the histopathological aspect of skin lesions. 
Localized cutaneous leishmaniasis caused by L. (L.) 
amazonensis shows a dense inflammatory infiltrate of 
vacuolated macrophages in the dermis with a large number 
of amastigote forms, giving to the infiltrate the appearance 
of a macrophagic granuloma. This morphological aspect 
of the skin lesion differs from the localized cutaneous 
leishmaniasis cases caused by L. (V.) braziliensis and 
other species of the subgenus Viannia, where there is a 
predominance of a more modest infiltrate of macrophages 
with a generally scarce parasite load, however, lymphocytes 
and plasma cells are more frequent in the presence of well-
formed epithelioid granulomas7,34,50.
CONCLUSIONS
In conclusion, the histopathological changes observed in 
localized CL caused by L. (V.) panamensis in Panama were 
characterized by an intense inflammatory reaction in the 
dermis with diffuse predominance and lymphohistiocytic, 
lymphoplasmocytic and granulomatous presentation 
patterns, as well as the presence of ulcers, acanthosis, 
exocytosis and spongiosis in the epidermis. However, 
Rev Inst Med Trop São Paulo. 2018;60:e8
Histopathological characteristics of cutaneous lesions caused by Leishmania Viannia panamensis in Panama
Page 7 of 9
none of them are specific to establish the diagnosis by 
histopathology. Under the conditions described above, 
the sensitivity of the histopathological technique in the 
diagnosis of CL caused by L. (V.) panamensis was 48%.
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